Phase II study of oral S-1 plus irinotecan in patients with advanced gastric cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0303
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 01 Jan 2006 New trial record.